Table 4 Efficacy according to study group (per protocol analysis)
CQ (N = 41) | CQ-MB (N = 163) | |
|---|---|---|
Clinical failure (CF) | 22 (53.7%) | 73 (44.0%) |
Early treatment failure (ETF) | 15 (36.6%) | 48 (28.9%) |
Late clinical failure (LCF) | 7 (17.1%) | 25 (15.1%) |
Late parasitological failure (LPF) | 5 (12.2%) | 21 (12.9%) |